PubMed Health⌕ Search

Biomedical subjects

M Kumano

Publications and source records attributed to M Kumano.

At least 37 records · Page 2Linked to original sources
PubMed1984

Chemoprophylaxis of malaria in non-immune residents in Dar es Salaam, Tanzania.

The malaria infection rates in non-immune residents of Dar es Salaam on various chemoprophylactic regimens were compared with that (37.1%) in those not taking prophylactic antimalarials. Among 647 people resident in Dar es Salaam for 1-6 years the two groups with the lowest infection rates by person-episodes (2.0% and 1.5%) were those taking proguanil 200 mg daily alone or with chloroquine base 300 mg weekly. Infection rates (16.9% and 14.0%) were also significantly lower than in the no-prophylaxis group in those taking chloroquine base 300 mg weekly combined with 'Fansidar', 'Maloprim' (each one tablet weekly), or proguanil 100 mg daily. No significant reduction in the malaria attack rate was found in those taking chloroquine base 300 mg or 600 mg weekly (31.2%), pyrimethamine 25 mg weekly (27.3%), proguanil 100 mg daily (46.4%), maloprim one tablet weekly (40.4%), or a combination of chloroquine base 300 mg weekly and pyrimethamine 25 mg weekly (27.1%). Similar results were obtained when the infection rates per year of exposure were compared. Proguanil was associated with fewest user complaints and fansidar with most.

Adolescent↗
PubMed1984

[Central nervous system irradiation for children with leukemia].

Between 1972 and 1981, 247 patients with acute lymphoblastic leukemia were treated with prophylactic CNS irradiation. Cranial irradiation (2400 rad) plus intrathecal methotrexate was the prophylactic CNS therapy of choice. At 5 years, the overall, relapse-free and CNS relapse-free survival rates were 51%, 47% and 79%, respectively. Our findings suggest that more attention should be paid to the inferior border of the radiation field, since the anterior and middle cranial fossae were sometimes not included and the second spine was almost always excluded.

Adolescent↗
PubMed1984

[Prophylactic central nervous system irradiation for childhood acute lymphoblastic leukemia].

Documentation on 324 children with leukemia who underwent cranial irradiation between 1972 and 1981 was collected from 15 participating hospitals in the Kansai Cancer therapy Group. Among 182 children with acute lymphoblastic leukemia, records on 90 children treated with prophylactic cranial irradiation (2,400 rads) plus intrathecal methotrexate in 12 hospitals were available for analysis. There was no significant difference in survival between the two prognostic groups based on age and initial WBC count at diagnosis, i.e., overall, relapse-free and CNS relapse-free 5-year survivals in the good and intermediate prognostic groups were 57% vs. 51%, 55%, vs. 49%, and 83% vs. 95%, respectively.

Adolescent↗
PubMed1981

The effect of RES blockade on red blood cell survival.

The effect of RES blockade on the survival of heat-damaged and antibody coated red blood cells was evaluated in C3H mice. RES function of C3H mice was determined by the survival of 59Fe-labeled, heat-damaged red blood cells at 49 degrees C for 30 min. When animals were treated with an intravenous injection of non-labeled, heat-damaged red blood cells for the blockade of RES, red blood cell destruction was depressed in non-splenectomized and splenectomized mice. In the survival or organ distribution of 59Fe-labeled, antibody-coated red blood cells, no difference was noted between animals with and without blockade. These findings suggest that heat-damaged red blood cells were destructed predominantly in the splenic RES and antibody coated cells were not broken down only by the splenic RES.

Animals↗